New target gives hope for better treatments for incurable myeloma

Researchers have discovered a new target for treating treating multiple myeloma, an incurable bone marrow cancer.

The research revealed that the majority of myelomas rely on a protein called MCL-1 to stay alive. Potential drugs that inhibit MCL-1, which are in pre-clinical development, may be a promising new treatment for multiple myeloma.

Each year more than 1700 Australians are diagnosed with multiple myeloma, which is a cancer of immune cells called plasma cells. Currently available treatments are only able to halt the progression of the disease and relieve symptoms, but cannot cure the disease.

Walter and Eliza Hall Institute researchers Dr Jianan Gong, Dr David Segal, Ms Yuan Yao, Professor Andrew Roberts and Professor David Huang, working with researchers at the Australian Centre for Blood Diseases, Monash University and theAlfred Hospital, investigated the ‘survival proteins’ that keep myeloma cells alive, allowing the cancer to persist.

Read at Walter+Eliza Hall Institute of Medical Research

Omega Fish Oils And Vitamin D Might Boost Antidepressants’ Effects, University of Melbourne Study

Nutrient Supplements Can Give Antidepressants A Boost

An international evidence review has found that certain nutritional supplements can increase the effectiveness of antidepressants for people with clinical depression.

Omega 3 fish oils, S-adenosylmethionine (SAMe)*, methylfolate (bioactive form of folate) and Vitamin D, were all found to boost the effects of medication.

University of Melbourne and Harvard researchers examined 40 clinical trials worldwide, alongside a systematic review of the evidence for using nutrient supplements (known as nutraceuticals) to treat clinical depression in tandem with antidepressants such as SSRIs**, SNRIs^ and tricyclics^^.

Head of the ARCADIA Mental Health Research Group at the University of Melbourne, Dr Jerome Sarris, led the meta-analysis, published today in the American Journal of Psychiatry.

“The strongest finding from our review was that Omega 3 fish oil – in combination with antidepressants – had a statistically significant effect over a placebo,” Dr Sarris said.

 

Read at BioSpace

Fears over powerful new strain of gonorrhoea

Concerns are mounting over a powerful new form of gonorrhoea after a patient was found to have the highest level of drug resistance to the disease ever reported in Australia.

It is understood the patient, a tourist from central Europe, contracted the “sex superbug” in Sydney and was eventually treated in Cairns.

The discovery of the case in Australia, which resulted in a health alert in July, has also prompted warnings in New Zealand, where sexual health clinics are on high alert amid fears the new strain will spread there.

NZ Sexual Health Society president Edward Coughlan warned the patient involved, who is believed to have left the country, had the highest level of gonorrhoea drug resistance ever reported in Australia.

 

Read full story on TheGuardian

How Owensboro tobacco grew a possible miracle drug to treat Ebola

When two American aid workers came down with the deadly Ebola virus recently, an experimental treatment materialized seemingly out of nowhere. How did a possible miracle drug for one of the deadliest diseases in Africa come to be grown half a world away in a small town in Kentucky?

Because of chewing tobacco, malaria, Charles Darwin and Australia.

For decades, tobacco has been a solution in search of the right problem, and Ebola might be that problem.

In the 1990s, when smoking rates slipped below 30 percent, Kentucky tobacco farmers began to look for another way to make money. And a lot of eyes turned to Daviess County.